t
Convatec Group Plc held its Annual General Meeting on May 21, 2026, where all resolutions set out in the Notice of Meeting, except resolution 9, were passed by a poll. Resolution 9, concerning the re-election of Professor Constantin Coussios, was withdrawn as he had stepped down on April 30, 2026. The Remuneration Report resolution passed with 65.77% of votes for, and overall, 82.99% of the company's total issued share capital of 1,954,852,029 shares was voted.
| Date | 21 May 2026 |
| Time | 15:30:00 |
| Category | AGMs and other meetings |
| ID | 3371F |
21 May 2026
Convatec Group Plc
(Convatec or the Company)
Results of the Annual General Meeting
Convatec's Annual General Meeting (AGM) was held at 20 Eastbourne Terrace, Paddington, London, W2 6LG on Thursday, 21 May 2026 at 14:00.
All resolutions set out in the Notice of Meeting were duly passed by way of a poll. The results are set out below:
|
|
For1 |
Against1 |
Votes total |
% of ISC voted3 |
Withheld2 |
|||
|
Resolution |
No of shares |
% |
No of shares |
% |
||||
|
1 |
2025 Annual Reports and Accounts |
1,583,600,321 |
97.97% |
32,856,766 |
2.03% |
1,616,457,087 |
82.69% |
5,973,533 |
|
2 |
Remuneration Report |
1,057,723,791 |
65.77% |
550,589,931 |
34.23% |
1,608,313,722 |
82.27% |
14,116,898 |
|
3 |
Dividend |
1,584,518,305 |
97.96% |
32,961,425 |
2.04% |
1,617,479,730 |
82.74% |
4,950,890 |
|
4 |
Elect Fiona Ryder |
1,578,260,187 |
97.58% |
39,097,452 |
2.42% |
1,617,357,639 |
82.74% |
5,072,981 |
|
5 |
Re-elect Dr John McAdam |
1,546,263,951 |
95.60% |
71,094,592 |
4.40% |
1,617,358,543 |
82.74% |
5,072,077 |
|
6 |
Re-elect Jonny Mason |
1,580,750,694 |
97.73% |
36,713,081 |
2.27% |
1,617,463,775 |
82.74% |
4,966,845 |
|
7 |
Re-elect Margaret Ewing |
1,568,485,590 |
96.98% |
48,871,739 |
3.02% |
1,617,357,329 |
82.74% |
5,073,291 |
|
8 |
Re-elect Brian May |
1,534,104,114 |
94.85% |
83,252,311 |
5.15% |
1,617,356,425 |
82.74% |
5,074,195 |
|
9 |
Re-elect Professor Constantin Coussios4 |
WITHDRAWN |
||||||
|
10 |
Re-elect Kim Lody |
1,566,266,564 |
96.84% |
51,089,725 |
3.16% |
1,617,356,289 |
82.74% |
5,074,331 |
|
11 |
Re-elect Heather Mason |
1,570,362,017 |
97.09% |
46,995,312 |
2.91% |
1,617,357,329 |
82.74% |
5,073,291 |
|
12 |
Re-elect Sharon O'Keefe |
1,565,589,732 |
96.80% |
51,764,294 |
3.20% |
1,617,354,026 |
82.74% |
5,076,594 |
|
13 |
Appoint Ernst & Young LLP as auditors |
1,584,246,288 |
97.95% |
33,122,017 |
2.05% |
1,617,368,305 |
82.74% |
5,062,315 |
|
14 |
Auditors' remuneration |
1,584,397,363 |
97.96% |
32,969,022 |
2.04% |
1,617,366,385 |
82.74% |
5,064,235 |
|
15 |
Political donations |
1,526,399,577 |
94.09% |
95,877,488 |
5.91% |
1,622,277,065 |
82.99% |
153,555 |
|
16 |
Allotment of shares |
1,399,668,923 |
86.54% |
217,704,840 |
13.46% |
1,617,373,763 |
82.74% |
5,056,857 |
|
17 |
Disapplication of pre-emption rights* |
1,509,552,149 |
93.33% |
107,800,388 |
6.67% |
1,617,352,537 |
82.74% |
5,078,083 |
|
18 |
Further disapplication of pre-emption rights* |
1,403,547,455 |
86.78% |
213,807,368 |
13.22% |
1,617,354,823 |
82.74% |
5,075,797 |
|
19 |
Purchase of own shares* |
1,583,783,948 |
97.95% |
33,142,423 |
2.05% |
1,616,926,371 |
82.71% |
5,504,249 |
|
20
|
Notice for General Meetings* |
1,466,844,869 |
90.69% |
150,521,910 |
9.31% |
1,617,366,779 |
82.74% |
5,063,841 |
Notes to the disclosure:
*Special Resolution.
1. Votes "For" and "Against" are expressed as a percentage of votes received.
2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
3. Total number of shares in issue is 1,954,852,029 (82.99% of capital was voted).
4. As announced on 13 April 2026, Professor Constantin Coussios stepped down from his role as Non-executive Director of the Company on 30 April 2026. Accordingly, the resolution to re-elect Professor Constantin Coussios as a director of the Company (resolution 9 in the Notice of Meeting) was withdrawn.
5. Computershare acted as scrutineer of the poll on all resolutions.
The Board is pleased that all resolutions were supported at today's AGM. We recognise the vote for Resolution 2 (Remuneration Report) was below 80%. We will continue to engage with and listen to the views of shareholders and the proxy advisers on remuneration matters, building on the engagement carried out with c. 85% of our shareholders prior to the meeting. An update on that engagement, and on any action taken as a result of these votes, will be published within six months of the AGM in accordance with the UK Corporate Governance Code, with a final summary to be included in the Company's 2026 Annual Report.
In accordance with UKLR 6.4.2, copies of the resolutions that do not constitute ordinary business that were passed at the Annual General Meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
James Kerton
Company Secretary
Email: [email protected]
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
Classification: 3.1 Additional regulated information required to be disclosed under the laws of the United Kingdom
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com